Mentice AB (publ) (MNTC) Earnings Call Transcripts
Mentice AB (publ)'s Latest Earnings Call - Q1 FY2026
In Q1 2026, Mentice AB reported revenues of SEK 62 million, reflecting a 26% organic growth and a 14% year-over-year increase after adjusting for foreign exchange. The order intake surged to SEK 59 million, marking a remarkable 50% growth, which signals strong demand across its Medical Device Industry and Healthcare Systems segments. Management maintained a positive outlook, emphasizing sustained momentum and a healthy project funnel, while also indicating ongoing cost discipline despite a negative EBITDA margin.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | SEK 62 million (beat) |
| Order Intake | SEK 59 million (beat) |
| EBITDA Margin | -5% (positive) |
| Healthcare Systems Growth | 31% (positive) |
| Operating Expenses | SEK 20 million (positive) |
| Order Book | SEK 127 million (positive) |
Guidance from management
Management indicated a strong project funnel and sustained momentum, with expectations for continued growth in both the Medical Device Industry and Healthcare Systems segments. They aim for a 20% EBITDA margin in the future, contingent on revenue growth.
What management said
Thank you, Maria. Thanks for having us. I'm here alone today. Ulrika can unfortunately not be here in person, but she is on the call and she was able to assist me also in the presentation.
Nothing I want to add more than just again emphasize, this is the third strongest quarter in a row, which we see in all different aspects. So that's my only addition to what you've said.
What analysts pressed on
Analysts expressed concerns regarding the negative EBITDA margin and the potential impact of product mix and tariffs on gross margins. There were questions about the sustainability of growth in the Americas region after a slight decline.
Main topics on the call
- Revenue Growth Acceleration — Mentice achieved SEK 62 million in revenues for Q1 2026, representing a 26% organic growth. CEO Frans Venker stated, "the trend is really in the right direction," highlighting a significant improvement compared to Q1 202...
- Strong Order Intake — The order intake reached SEK 59 million, a 50% increase, indicating robust demand. Venker noted, "the order book that we have now of SEK 127 million will generate SEK 84 million of revenue already again in 2026," suggest...
- Improved EBITDA Margin — While the EBITDA margin remains negative, it showed significant improvement year-over-year. Venker mentioned, "the EBITDA trend is also in the upward trajectory again," signaling potential for future profitability.
- Geographic Growth Variability — Growth was particularly strong in the EMEA and Asia Pacific regions, with EMEA showing a 46% year-over-year increase. Venker acknowledged, "Americas had a minus 4% development," but expressed confidence in future growth.
Read the full Mentice AB (publ) transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Mentice AB (publ)
Mentice AB (publ) (MNTC) is a publicly listed company in the Health Care Technology industry, within the Health Care sector. It trades on OM and is based in SE. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 26 calls on record spanning February 27, 2020 to July 23, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 26 Mentice AB (publ) earnings call transcripts on record, spanning February 27, 2020 to July 23, 2026. Based on this history, Mentice AB (publ) reports quarterly. The most recent call on file is dated July 23, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- MNTC
- Exchange
- OM
- Country
- SE
- Sector
- Health Care
- Industry
- Health Care Technology
- Calls on record
- 26
- First call
- February 27, 2020
- Most recent
- July 23, 2026
- Reporting cadence
- quarterly